Grifols, a global company established in 1909, is dedicated to improving the health and well-being of individuals worldwide. With a rich history rooted in scientific expertise and a commitment to serving patients and society, Grifols develops, produces, and markets innovative medicines, solutions, and services in over 110 countries.
Driven by a passion for innovation, Grifols is at the forefront of developing breakthroughs in various therapeutic areas, leveraging their extensive knowledge of plasma to transform healthcare. Their sustainable approach extends beyond their products, as they actively support donors, patients, and the environment, making a positive impact on society as a whole.
Generated from the website
